1
|
Lebrun LJ, Pallot G, Nguyen M, Tavernier A, Dusuel A, Pilot T, Deckert V, Dugail I, Le Guern N, Pais De Barros JP, Benkhaled A, Choubley H, Lagrost L, Masson D, Gautier T, Grober J. Increased Weight Gain and Insulin Resistance in HF-Fed PLTP Deficient Mice Is Related to Altered Inflammatory Response and Plasma Transport of Gut-Derived LPS. Int J Mol Sci 2022; 23:13226. [PMID: 36362012 PMCID: PMC9654699 DOI: 10.3390/ijms232113226] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2022] [Revised: 10/24/2022] [Accepted: 10/26/2022] [Indexed: 11/15/2023] Open
Abstract
Bacterial lipopolysaccharides (LPS, endotoxins) are found in high amounts in the gut lumen. LPS can cross the gut barrier and pass into the blood (endotoxemia), leading to low-grade inflammation, a common scheme in metabolic diseases. Phospholipid transfer protein (PLTP) can transfer circulating LPS to plasma lipoproteins, thereby promoting its detoxification. However, the impact of PLTP on the metabolic fate and biological effects of gut-derived LPS is unknown. This study aimed to investigate the influence of PLTP on low-grade inflammation, obesity and insulin resistance in relationship with LPS intestinal translocation and metabolic endotoxemia. Wild-type (WT) mice were compared with Pltp-deficient mice (Pltp-KO) after a 4-month high-fat (HF) diet or oral administration of labeled LPS. On a HF diet, Pltp-KO mice showed increased weight gain, adiposity, insulin resistance, lipid abnormalities and inflammation, together with a higher exposure to endotoxemia compared to WT mice. After oral administration of LPS, PLTP deficiency led to increased intestinal translocation and decreased association of LPS to lipoproteins, together with an altered catabolism of triglyceride-rich lipoproteins (TRL). Our results show that PLTP, by modulating the intestinal translocation of LPS and plasma processing of TRL-bound LPS, has a major impact on low-grade inflammation and the onset of diet-induced metabolic disorders.
Collapse
Affiliation(s)
- Lorène J. Lebrun
- INSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France
- FCS Bourgogne-Franche Comté, LipSTIC LabEx, 21000 Dijon, France
- Institut Agro Dijon, 1 Esplanade Erasme, 21000 Dijon, France
| | - Gaëtan Pallot
- INSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France
- FCS Bourgogne-Franche Comté, LipSTIC LabEx, 21000 Dijon, France
| | - Maxime Nguyen
- INSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France
- FCS Bourgogne-Franche Comté, LipSTIC LabEx, 21000 Dijon, France
- Department of Anesthesiology and Intensive Care, Dijon University Hospital, 21000 Dijon, France
| | - Annabelle Tavernier
- INSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France
- FCS Bourgogne-Franche Comté, LipSTIC LabEx, 21000 Dijon, France
- Institut Agro Dijon, 1 Esplanade Erasme, 21000 Dijon, France
| | - Alois Dusuel
- INSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France
- FCS Bourgogne-Franche Comté, LipSTIC LabEx, 21000 Dijon, France
| | - Thomas Pilot
- INSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France
- FCS Bourgogne-Franche Comté, LipSTIC LabEx, 21000 Dijon, France
| | - Valérie Deckert
- INSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France
- FCS Bourgogne-Franche Comté, LipSTIC LabEx, 21000 Dijon, France
| | - Isabelle Dugail
- Faculté de Médecine Pitié-Salpêtrière, UMR1269, 75000 Paris, France
| | - Naig Le Guern
- INSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France
- FCS Bourgogne-Franche Comté, LipSTIC LabEx, 21000 Dijon, France
| | - Jean-Paul Pais De Barros
- INSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France
- FCS Bourgogne-Franche Comté, LipSTIC LabEx, 21000 Dijon, France
- Lipidomic Analytic Plate-Forme, UBFC, Bâtiment B3, 21000 Dijon, France
| | - Anissa Benkhaled
- INSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France
- FCS Bourgogne-Franche Comté, LipSTIC LabEx, 21000 Dijon, France
| | - Hélène Choubley
- INSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France
- FCS Bourgogne-Franche Comté, LipSTIC LabEx, 21000 Dijon, France
- Lipidomic Analytic Plate-Forme, UBFC, Bâtiment B3, 21000 Dijon, France
| | - Laurent Lagrost
- INSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France
- FCS Bourgogne-Franche Comté, LipSTIC LabEx, 21000 Dijon, France
| | - David Masson
- INSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France
- FCS Bourgogne-Franche Comté, LipSTIC LabEx, 21000 Dijon, France
- Laboratory of Clinical Chemistry, François Mitterrand University Hospital, 21000 Dijon, France
| | - Thomas Gautier
- INSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France
- FCS Bourgogne-Franche Comté, LipSTIC LabEx, 21000 Dijon, France
| | - Jacques Grober
- INSERM, LNC UMR1231, Université Bourgogne Franche-Comté, 21000 Dijon, France
- FCS Bourgogne-Franche Comté, LipSTIC LabEx, 21000 Dijon, France
- Institut Agro Dijon, 1 Esplanade Erasme, 21000 Dijon, France
| |
Collapse
|
2
|
Skaar EP. Imaging Infection Across Scales of Size: From Whole Animals to Single Molecules. Annu Rev Microbiol 2021; 75:407-426. [PMID: 34343016 DOI: 10.1146/annurev-micro-041521-121457] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Infectious diseases are a leading cause of global morbidity and mortality, and the threat of infectious diseases to human health is steadily increasing as new diseases emerge, existing diseases reemerge, and antimicrobial resistance expands. The application of imaging technology to the study of infection biology has the potential to uncover new factors that are critical to the outcome of host-pathogen interactions and to lead to innovations in diagnosis and treatment of infectious diseases. This article reviews current and future opportunities for the application of imaging to the study of infectious diseases, with a particular focus on the power of imaging objects across a broad range of sizes to expand the utility of these approaches. Expected final online publication date for the Annual Review of Microbiology, Volume 75 is October 2021. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.
Collapse
Affiliation(s)
- Eric P Skaar
- Vanderbilt Institute for Infection, Immunology, and Inflammation, Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA;
| |
Collapse
|
3
|
Kwon YD, Byun Y, Kim HK. 18F-labelled BODIPY dye as a dual imaging agent: Radiofluorination and applications in PET and optical imaging. Nucl Med Biol 2021; 93:22-36. [PMID: 33276283 DOI: 10.1016/j.nucmedbio.2020.11.004] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2020] [Revised: 11/05/2020] [Accepted: 11/11/2020] [Indexed: 12/19/2022]
Abstract
Dual Positron emission tomography (PET)/optical imaging techniques have captured scientific interest for clinical applications due to their potential as an effective tool for visualizing in vivo information such as disease processes. 4,4'-Difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY) dye has been considered an ideal platform strategy to achieve dual PET/optical imaging due to its photochemical nature and chemical structure. Various radiofluorination methods to prepare [18F]BODIPY dye have been developed and established, ranging from nucleophilic substitution reactions to isotope exchange reactions. In addition, 18F-labelled BODIPY dyes for biologically important targets have been used for in vivo and ex vivo studies. These studies proved the practicality of [18F]BODIPY dyes as a hybrid PET/optical imaging probe. In this review, recent advances in the synthesis and biological evaluation of 18F-labelled BODIPY dyes are described.
Collapse
Affiliation(s)
- Young-Do Kwon
- Department of Chemistry, Rice University, Houston, TX 77005, USA; Department of Nuclear Medicine, Molecular Imaging & Therapeutic Medicine Research Center, Jeonbuk National University Medical School and Hospital, Jeonju 54907, Republic of Korea; Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju 54907, Republic of Korea
| | - Youngjoo Byun
- College of Pharmacy, Korea University, Sejong 30019, Republic of Korea
| | - Hee-Kwon Kim
- Department of Nuclear Medicine, Molecular Imaging & Therapeutic Medicine Research Center, Jeonbuk National University Medical School and Hospital, Jeonju 54907, Republic of Korea; Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju 54907, Republic of Korea.
| |
Collapse
|
4
|
Hadi T, Ramseyer C, Gautier T, Bellaye PS, Lopez T, Schmitt A, Foley S, Yesylevskyy S, Minervini T, Douhard R, Dondaine L, Proukhnitzky L, Messaoudi S, Wendremaire M, Moreau M, Neiers F, Collin B, Denat F, Lagrost L, Garrido C, Lirussi F. Lipoproteins LDL versus HDL as nanocarriers to target either cancer cells or macrophages. JCI Insight 2020; 5:140280. [PMID: 33252359 PMCID: PMC7819744 DOI: 10.1172/jci.insight.140280] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2020] [Accepted: 11/11/2020] [Indexed: 01/01/2023] Open
Abstract
In this work, we have explored natural unmodified low- and high-density lipoproteins (LDL and HDL, respectively) as selective delivery vectors in colorectal cancer therapy. We show in vitro in cultured cells and in vivo (NanoSPECT/CT) in the CT-26 mice colorectal cancer model that LDLs are mainly taken up by cancer cells, while HDLs are preferentially taken up by macrophages. We loaded LDLs with cisplatin and HDLs with the heat shock protein-70 inhibitor AC1LINNC, turning them into a pair of “Trojan horses” delivering drugs selectively to their target cells as demonstrated in vitro in human colorectal cancer cells and macrophages, and in vivo. Coupling of the drugs to lipoproteins and stability was assessed by mass spectometry and raman spectrometry analysis. Cisplatin vectorized in LDLs led to better tumor growth suppression with strongly reduced adverse effects such as renal or liver toxicity. AC1LINNC vectorized into HDLs induced a strong oxidative burst in macrophages and innate anticancer immune response. Cumulative antitumor effect was observed for both drug-loaded lipoproteins. Altogether, our data show that lipoproteins from patient blood can be used as natural nanocarriers allowing cell-specific targeting, paving the way toward more efficient, safer, and personalized use of chemotherapeutic and immunotherapeutic drugs in cancer.
Collapse
Affiliation(s)
- Tarik Hadi
- INSERM, U1231, Label LipSTIC, and Ligue Nationale contre le Cancer, Dijon, France.,Université de Bourgogne-Franche Comté, France.,NYU Langone Medical Center, department of Cardiac Surgery, New York, New York, USA
| | - Christophe Ramseyer
- Université de Bourgogne-Franche Comté, France.,Laboratoire Chrono Environnement UMR CNRS 6249, Université de Bourgogne Franche-Comté, Besançon Cedex, France
| | - Thomas Gautier
- INSERM, U1231, Label LipSTIC, and Ligue Nationale contre le Cancer, Dijon, France.,Université de Bourgogne-Franche Comté, France
| | | | - Tatiana Lopez
- INSERM, U1231, Label LipSTIC, and Ligue Nationale contre le Cancer, Dijon, France.,Université de Bourgogne-Franche Comté, France
| | - Antonin Schmitt
- INSERM, U1231, Label LipSTIC, and Ligue Nationale contre le Cancer, Dijon, France.,Anti-cancer Center George-François Leclerc, CGFL, Dijon, France
| | - Sarah Foley
- Université de Bourgogne-Franche Comté, France.,Laboratoire Chrono Environnement UMR CNRS 6249, Université de Bourgogne Franche-Comté, Besançon Cedex, France
| | - Semen Yesylevskyy
- Laboratoire Chrono Environnement UMR CNRS 6249, Université de Bourgogne Franche-Comté, Besançon Cedex, France.,Department of Physics of Biological Systems, Institute of Physics of the National Academy of Sciences of Ukraine, Kyiv, Ukraine
| | - Thibault Minervini
- Université de Bourgogne-Franche Comté, France.,Laboratoire Chrono Environnement UMR CNRS 6249, Université de Bourgogne Franche-Comté, Besançon Cedex, France
| | - Romain Douhard
- INSERM, U1231, Label LipSTIC, and Ligue Nationale contre le Cancer, Dijon, France.,Université de Bourgogne-Franche Comté, France
| | - Lucile Dondaine
- INSERM, U1231, Label LipSTIC, and Ligue Nationale contre le Cancer, Dijon, France.,Université de Bourgogne-Franche Comté, France
| | - Lil Proukhnitzky
- INSERM, U1231, Label LipSTIC, and Ligue Nationale contre le Cancer, Dijon, France.,Université de Bourgogne-Franche Comté, France
| | - Samir Messaoudi
- BioCIS, Univ. Paris-Sud, CNRS, Univ. Paris-Saclay, Châtenay-Malabry, France
| | - Maeva Wendremaire
- INSERM, U1231, Label LipSTIC, and Ligue Nationale contre le Cancer, Dijon, France.,Université de Bourgogne-Franche Comté, France
| | - Mathieu Moreau
- ICMUB, Institut de Chimie Moléculaire de l'Université de Bourgogne, UMR6302, CNRS, Université Bourgogne Franche-Comté, Dijon, France
| | - Fabrice Neiers
- Centre des Sciences du Goût et de l'Alimentation, INRA, CNRS, Bourgogne Franche-Comté University, France
| | - Bertrand Collin
- Université de Bourgogne-Franche Comté, France.,Anti-cancer Center George-François Leclerc, CGFL, Dijon, France
| | - Franck Denat
- ICMUB, Institut de Chimie Moléculaire de l'Université de Bourgogne, UMR6302, CNRS, Université Bourgogne Franche-Comté, Dijon, France
| | - Laurent Lagrost
- INSERM, U1231, Label LipSTIC, and Ligue Nationale contre le Cancer, Dijon, France.,Université de Bourgogne-Franche Comté, France
| | - Carmen Garrido
- INSERM, U1231, Label LipSTIC, and Ligue Nationale contre le Cancer, Dijon, France.,Université de Bourgogne-Franche Comté, France.,Anti-cancer Center George-François Leclerc, CGFL, Dijon, France
| | - Frederic Lirussi
- INSERM, U1231, Label LipSTIC, and Ligue Nationale contre le Cancer, Dijon, France.,Université de Bourgogne-Franche Comté, France.,University Hospital of Besançon (CHU), France
| |
Collapse
|
5
|
Slikboer SR, Pitchumony TS, Banevicius L, Mercanti N, Edem PE, Valliant JF. Imidazole fused phenanthroline (PIP) ligands for the preparation of multimodal Re(I) and 99mTc(I) probes. Dalton Trans 2020; 49:14826-14836. [PMID: 33034336 DOI: 10.1039/d0dt02829k] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
A small library of [2 + 1] 99mTc(i) complexes based on phenyl-imidazole-fused phenanthroline (PIP) ligands were synthesized and evaluated as multimodal molecular imaging probes. Using either a two-step or a one-pot synthesis method, 99mTc-PIP complexes containing N-methylimidazole as the monodentate ligand were prepared and isolated in good (54 to 89%) radiochemical yield, with the exception of one derivative bearing a strongly electron-withdrawing substituent. The stability of the [2 + 1] complexes was assessed in saline and in cysteine and histidine challenge studies, showing 6 hours stability, making them suitable for in vivo studies. In parallel, the Re(i) analogues were prepared as reference standards to verify the structure of the 99mTc complexes. The optical properties were consistent with other previously reported [2 + 1] type Re(i) complexes that have been used as cellular dyes and sensors. To facilitate the development of targeted derivatives, a tetrazine-PIP ligand was also synthesized. The 99mTc complex of the tetrazine PIP ligand effectively coupled to compounds containing a trans-cyclooctene (TCO) group including a TCO-albumin derivative, which was prepared as a model targeting molecule. An added benefit of the Re-PIP-Tz construct is that the emission from the metal complex was quenched by the presence of the tetrazine. Following the addition of TCO, there was a 70-fold increase in fluorescence emission, which can in future be leveraged during in vitro studies to reduce background signal.
Collapse
Affiliation(s)
- Samantha R Slikboer
- Department of Chemistry and Chemical Biology, McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4 M1, Canada.
| | | | | | | | | | | |
Collapse
|
6
|
Lee JY, Mushtaq S, Park JE, Shin HS, Lee SY, Jeon J. Radioanalytical Techniques to Quantitatively Assess the Biological Uptake and In Vivo Behavior of Hazardous Substances. Molecules 2020; 25:molecules25173985. [PMID: 32882977 PMCID: PMC7504758 DOI: 10.3390/molecules25173985] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2020] [Revised: 08/24/2020] [Accepted: 08/27/2020] [Indexed: 12/25/2022] Open
Abstract
Concern about environmental exposure to hazardous substances has grown over the past several decades, because these substances have adverse effects on human health. Methods used to monitor the biological uptake of hazardous substances and their spatiotemporal behavior in vivo must be accurate and reliable. Recent advances in radiolabeling chemistry and radioanalytical methodologies have facilitated the quantitative analysis of toxic substances, and whole-body imaging can be achieved using nuclear imaging instruments. Herein, we review recent literature on the radioanalytical methods used to study the biological distribution, changes in the uptake and accumulation of hazardous substances, including industrial chemicals, nanomaterials, and microorganisms. We begin with an overview of the radioisotopes used to prepare radiotracers for in vivo experiments. We then summarize the results of molecular imaging studies involving radiolabeled toxins and their quantitative assessment. We conclude the review with perspectives on the use of radioanalytical methods for future environmental research.
Collapse
Affiliation(s)
- Jae Young Lee
- Department of Environmental and Safety Engineering, Ajou University, Suwon 16499, Korea;
| | - Sajid Mushtaq
- Department of Nuclear Engineering, Pakistan Institute of Engineering and Applied Sciences, Islamabad 45650, Pakistan;
| | - Jung Eun Park
- Department of Applied Chemistry, School of Applied Chemical Engineering, Kyungpook National University, Daegu 41566, Korea;
| | - Hee Soon Shin
- Division of Functional Food Research, Korea Food Research Institute, 245, Nongsaengmyeong-ro, Iseo-myeon, Wanju-gun, Jeollabuk-do 55365, Korea; (H.S.S.); (S.-Y.L.)
- Food Biotechnology Program, University of Science and Technology, Daejeon 34113, Korea
| | - So-Young Lee
- Division of Functional Food Research, Korea Food Research Institute, 245, Nongsaengmyeong-ro, Iseo-myeon, Wanju-gun, Jeollabuk-do 55365, Korea; (H.S.S.); (S.-Y.L.)
- Food Biotechnology Program, University of Science and Technology, Daejeon 34113, Korea
| | - Jongho Jeon
- Department of Applied Chemistry, School of Applied Chemical Engineering, Kyungpook National University, Daegu 41566, Korea;
- Correspondence: ; Tel.: +82-53-950-5584
| |
Collapse
|
7
|
Bodio E, Denat F, Goze C. BODIPYS and aza-BODIPY derivatives as promising fluorophores for in vivo molecular imaging and theranostic applications. J PORPHYR PHTHALOCYA 2020. [DOI: 10.1142/s1088424619501268] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Since their discovery in 1968, the BODIPYs dyes (4,4-difluoro-4-bora-3a, 4a diaza-s-indacene) have found an exponentially increasing number of applications in a large variety of scientific fields. In particular, studies reporting bioapplications of BODIPYs have increased dramatically. However, most of the time, only in vitro investigations have been reported. The in vivo potential of BODIPYs and aza-BODIPYs is more recent, but considering the number of in vivo studies with BODIPY and aza-BODIPY which have been reported in the last five years, we can now affirm that this family of fluorophores can be considered important as cyanine dyes for future in vivo and even clinical applications. This review aims to present representative examples of recent in vivo applications of BODIPYs or aza-BODIPYs, and to highlight the potential of these dyes for optical molecular imaging.
Collapse
Affiliation(s)
- Ewen Bodio
- Institut de Chimie Moléculaire de l’Université de Bourgogne, UMR 6302, CNRS, Université Bourgogne Franche-Comté, 9 Avenue A. Savary, 21078 Dijon Cedex, France
| | - Franck Denat
- Institut de Chimie Moléculaire de l’Université de Bourgogne, UMR 6302, CNRS, Université Bourgogne Franche-Comté, 9 Avenue A. Savary, 21078 Dijon Cedex, France
| | - Christine Goze
- Institut de Chimie Moléculaire de l’Université de Bourgogne, UMR 6302, CNRS, Université Bourgogne Franche-Comté, 9 Avenue A. Savary, 21078 Dijon Cedex, France
| |
Collapse
|
8
|
Abstract
Fluorescence and SPECT/PET imaging are powerful tools currently in use by the scientific community and receiving a great attention for the development of dual-modality imaging agents. BODIPYs are among the most promising candidates to be used for such functions due their excellent absorbance and fluorescence properties as well as their ease of radiolabeling without compromising their biological properties. In this manuscript we present an overview of BODIPY radiolabeling methods and their relevance to the development of multimodality agents.
Collapse
Affiliation(s)
- Hasrat Ali
- Department of Nuclear Medicine and Radiobiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC, Canada J1H5N4, Canada
| | - René Ouellet
- Sherbrooke Molecular Imaging Centre, Centre de Recherche du CHUS (CRCHUS), 3001 12th North, Avenue, Sherbrooke, Canada
| | - Johan E. van Lier
- Department of Nuclear Medicine and Radiobiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC, Canada J1H5N4, Canada
- Sherbrooke Molecular Imaging Centre, Centre de Recherche du CHUS (CRCHUS), 3001 12th North, Avenue, Sherbrooke, Canada
| | - Brigitte Guérin
- Department of Nuclear Medicine and Radiobiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC, Canada J1H5N4, Canada
- Sherbrooke Molecular Imaging Centre, Centre de Recherche du CHUS (CRCHUS), 3001 12th North, Avenue, Sherbrooke, Canada
| |
Collapse
|
9
|
Sali W, Patoli D, Pais de Barros JP, Labbé J, Deckert V, Duhéron V, Le Guern N, Blache D, Chaumont D, Lesniewska E, Gasquet B, Paul C, Moreau M, Denat F, Masson D, Lagrost L, Gautier T. Polysaccharide Chain Length of Lipopolysaccharides From Salmonella Minnesota Is a Determinant of Aggregate Stability, Plasma Residence Time and Proinflammatory Propensity in vivo. Front Microbiol 2019; 10:1774. [PMID: 31428071 PMCID: PMC6688513 DOI: 10.3389/fmicb.2019.01774] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2019] [Accepted: 07/18/2019] [Indexed: 01/22/2023] Open
Abstract
Lipopolysaccharides (LPS) originate from the outer membrane of Gram-negative bacteria and trigger an inflammatory response via the innate immune system. LPS consist of a lipid A moiety directly responsible for the stimulation of the proinflammatory cascade and a polysaccharide chain of variable length. LPS form aggregates of variable size and structure in aqueous media, and the aggregation/disaggregation propensity of LPS is known as a key determinant of their biological activity. The aim of the present study was to determine to which extent the length of the polysaccharide chain can affect the nature of LPS structures, their pharmacokinetics, and eventually their proinflammatory properties in vivo. LPS variants of Salmonella Minnesota with identical lipid A but with different polysaccharide moieties were used. The physical properties of LPS aggregates were analyzed by zetametry, dynamic light scattering, and microscopy. The stability of LPS aggregates was tested in the presence of plasma, whole blood, and cultured cell lines. LPS pharmacokinetics was performed in wild-type mice. The accumulation in plasma of rough LPS (R-LPS) with a short polysaccharidic chain was lower, and its hepatic uptake was faster as compared to smooth LPS (S-LPS) with a long polysaccharidic chain. The inflammatory response was weaker with R-LPS than with S-LPS. As compared to S-LPS, R-LPS formed larger aggregates, with a higher hydrophobicity index, a more negative zeta potential, and a higher critical aggregation concentration. The lower stability of R-LPS aggregates could be illustrated in vitro by a higher extent of association of LPS to plasma lipoproteins, faster binding to blood cells, and increased uptake by macrophages and hepatocytes, compared to S-LPS. Our data indicate that a long polysaccharide chain is associated with the formation of more stable aggregates with extended residence time in plasma and higher inflammatory potential. These results show that polysaccharide chain length, and overall aggregability of LPS might be helpful to predict the proinflammatory effect that can be expected in experimental settings using LPS preparations. In addition, better knowledge and control of LPS aggregation and disaggregation might lead to new strategies to enhance LPS detoxification in septic patients.
Collapse
Affiliation(s)
- Wahib Sali
- LipSTIC LabEx, UMR1231, Lipids Nutrition Cancer, Inserm/University of Bourgogne Franche-Comté, Dijon, France
| | - Danish Patoli
- LipSTIC LabEx, UMR1231, Lipids Nutrition Cancer, Inserm/University of Bourgogne Franche-Comté, Dijon, France
| | - Jean-Paul Pais de Barros
- LipSTIC LabEx, UMR1231, Lipids Nutrition Cancer, Inserm/University of Bourgogne Franche-Comté, Dijon, France
| | - Jérôme Labbé
- LipSTIC LabEx, UMR1231, Lipids Nutrition Cancer, Inserm/University of Bourgogne Franche-Comté, Dijon, France
| | - Valérie Deckert
- LipSTIC LabEx, UMR1231, Lipids Nutrition Cancer, Inserm/University of Bourgogne Franche-Comté, Dijon, France
| | - Vincent Duhéron
- LipSTIC LabEx, UMR1231, Lipids Nutrition Cancer, Inserm/University of Bourgogne Franche-Comté, Dijon, France
| | - Naig Le Guern
- LipSTIC LabEx, UMR1231, Lipids Nutrition Cancer, Inserm/University of Bourgogne Franche-Comté, Dijon, France
| | - Denis Blache
- LipSTIC LabEx, UMR1231, Lipids Nutrition Cancer, Inserm/University of Bourgogne Franche-Comté, Dijon, France
| | - Denis Chaumont
- UMR6303 Laboratoire Interdisciplinaire Carnot de Bourgogne, CNRS/University of Bourgogne Franche-Comté, Dijon, France
| | - Eric Lesniewska
- UMR6303 Laboratoire Interdisciplinaire Carnot de Bourgogne, CNRS/University of Bourgogne Franche-Comté, Dijon, France
| | - Benoit Gasquet
- Cell Imaging platform, Inserm/University of Bourgogne Franche-Comté, Dijon, France
| | - Catherine Paul
- Laboratoire d'Immunologie et Immunothérapie des Cancers, EPHE, PSL Research University, Paris, France.,LIIC, EA7269, University of Bourgogne Franche-Comté, Dijon, France
| | - Mathieu Moreau
- Institut de Chimie Moléculaire de Bourgogne, UMR6302, CNRS/University of Bourgogne Franche-Comté, Dijon, France
| | - Franck Denat
- Institut de Chimie Moléculaire de Bourgogne, UMR6302, CNRS/University of Bourgogne Franche-Comté, Dijon, France
| | - David Masson
- LipSTIC LabEx, UMR1231, Lipids Nutrition Cancer, Inserm/University of Bourgogne Franche-Comté, Dijon, France.,University Hospital of Dijon, Dijon, France
| | - Laurent Lagrost
- LipSTIC LabEx, UMR1231, Lipids Nutrition Cancer, Inserm/University of Bourgogne Franche-Comté, Dijon, France.,University Hospital of Dijon, Dijon, France
| | - Thomas Gautier
- LipSTIC LabEx, UMR1231, Lipids Nutrition Cancer, Inserm/University of Bourgogne Franche-Comté, Dijon, France
| |
Collapse
|
10
|
Wang TC, Cochet F, Facchini FA, Zaffaroni L, Serba C, Pascal S, Andraud C, Sala A, Di Lorenzo F, Maury O, Huser T, Peri F. Synthesis of the New Cyanine-Labeled Bacterial Lipooligosaccharides for Intracellular Imaging and in Vitro Microscopy Studies. Bioconjug Chem 2019; 30:1649-1657. [DOI: 10.1021/acs.bioconjchem.9b00044] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Affiliation(s)
- Tung-Cheng Wang
- Biomolecular Photonics, Department of Physics, University of Bielefeld. Universitätsstraße 25, 33615 Bielefeld, Germany
| | - Florent Cochet
- Department of Biotechnology and Biosciences, University of Milano-Bicocca. Piazza della Scienza, 2, 20126 Milano, Italy
| | - Fabio Alessandro Facchini
- Department of Biotechnology and Biosciences, University of Milano-Bicocca. Piazza della Scienza, 2, 20126 Milano, Italy
| | - Lenny Zaffaroni
- Department of Biotechnology and Biosciences, University of Milano-Bicocca. Piazza della Scienza, 2, 20126 Milano, Italy
| | - Christelle Serba
- Laboratoire de Chimie, ENS de Lyon, 46 Allée d’Italie, 69364 Lyon Cedex 07, France
| | - Simon Pascal
- Laboratoire de Chimie, ENS de Lyon, 46 Allée d’Italie, 69364 Lyon Cedex 07, France
| | - Chantal Andraud
- Laboratoire de Chimie, ENS de Lyon, 46 Allée d’Italie, 69364 Lyon Cedex 07, France
| | - Andrea Sala
- Laboratoire de Chimie, ENS de Lyon, 46 Allée d’Italie, 69364 Lyon Cedex 07, France
| | - Flaviana Di Lorenzo
- Department of Chemical Sciences, University of Naples, 80126, Naples, Italy
- Task Force on Microbiome Studies, University of Naples Federico II, 80126 Naples, Italy
| | - Olivier Maury
- Laboratoire de Chimie, ENS de Lyon, 46 Allée d’Italie, 69364 Lyon Cedex 07, France
| | - Thomas Huser
- Biomolecular Photonics, Department of Physics, University of Bielefeld. Universitätsstraße 25, 33615 Bielefeld, Germany
| | - Francesco Peri
- Department of Biotechnology and Biosciences, University of Milano-Bicocca. Piazza della Scienza, 2, 20126 Milano, Italy
| |
Collapse
|
11
|
Sajedi S, Sabet H, Choi HS. Intraoperative biophotonic imaging systems for image-guided interventions. NANOPHOTONICS 2019; 8:99-116. [PMID: 31187017 PMCID: PMC6559750 DOI: 10.1515/nanoph-2018-0134] [Citation(s) in RCA: 36] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/07/2023]
Abstract
Biophotonic imaging has revolutionized the operation room by providing surgeons intraoperative image-guidance to diagnose tumors more efficiently and to resect tumors with real-time image navigation. Among many medical imaging modalities, near-infrared (NIR) light is ideal for image-guided surgery because it penetrates relatively deeply into living tissue, while nuclear imaging provides quantitative and unlimited depth information. It is therefore ideal to develop an integrated imaging system by combining NIR fluorescence and gamma-positron imaging to provide surgeons with highly sensitive and quantitative detection of diseases, such as cancer, in real-time without changing the look of the surgical field. The focus of this review is to provide recent progress in intraoperative biophotonic imaging systems, NIR fluorescence imaging and intraoperative nuclear imaging devices, and their future perspectives for image-guided interventions.
Collapse
Affiliation(s)
- Salar Sajedi
- Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
| | - Hamid Sabet
- Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
| | - Hak Soo Choi
- Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
| |
Collapse
|
12
|
Thakare V, Tran VL, Natuzzi M, Thomas E, Moreau M, Romieu A, Collin B, Courteau A, Vrigneaud JM, Louis C, Roux S, Boschetti F, Tillement O, Lux F, Denat F. Functionalization of theranostic AGuIX® nanoparticles for PET/MRI/optical imaging. RSC Adv 2019; 9:24811-24815. [PMID: 35528689 PMCID: PMC9073358 DOI: 10.1039/c9ra00365g] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2019] [Accepted: 08/01/2019] [Indexed: 12/16/2022] Open
Abstract
A novel trifunctional imaging probe containing a chelator of radiometal for PET, a NIR heptamethine cyanine dye, and a bioconjugatable handle, has been grafted onto AGuIX® nanoparticles via a Michael addition reaction. The resulting functionalized nanoparticles have been fully characterized, radiolabelled with 64Cu, and evaluated in a mice TSA tumor model using multimodal (PET/MRI/optical) imaging. The controlled dual functionalization of AGuIX® nanoparticles afforded trimodal imaging (PET/MRI/fluorescence) theranostic agents.![]()
Collapse
|
13
|
Wassenaar TM, Zimmermann K. Lipopolysaccharides in Food, Food Supplements, and Probiotics: Should We be Worried? Eur J Microbiol Immunol (Bp) 2018; 8:63-69. [PMID: 30345085 PMCID: PMC6186019 DOI: 10.1556/1886.2018.00017] [Citation(s) in RCA: 68] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2018] [Accepted: 07/16/2018] [Indexed: 01/01/2023] Open
Abstract
The fever-inducing effect of lipopolysaccharides (LPS) is well known, and human blood is extremely responsive to this pyrogen. Recently, the safety of LPS-containing food supplements and probiotic drugs as immune-stimulants has been questioned, although these products are orally taken and do not reach the bloodstream undigested. The concerns are understandable, as endotoxaemia is a pathological condition, but the oral uptake of probiotic products containing LPS or Gram-negative bacteria does not pose a health risk, based on the available scientific evidence, as is reviewed here. The available methods developed to detect LPS and other pyrogens are mostly used for quality control of parentally applied therapeuticals. Their outcome varies considerably when applied to food supplements, as demonstrated in a simple comparative experiment. Products containing different Escherichia coli strains can result in vastly different results on their LPS content, depending on the method of testing. This is an inherent complication to pyrogen testing, which hampers the communication that the LPS content of food supplements is not a safety concern.
Collapse
Affiliation(s)
- Trudy M Wassenaar
- Molecular Microbiology and Genomics Consultancy, Tannenstrasse 7, 55576 Zotzenheim, Germany
| | | |
Collapse
|
14
|
Ahn SH, Boros E. Nuclear and Optical Bimodal Imaging Probes Using Sequential Assembly: A Perspective. Cancer Biother Radiopharm 2018; 33:308-315. [PMID: 30004803 DOI: 10.1089/cbr.2018.2499] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023] Open
Abstract
New, targeted imaging tracers enable improved diagnosis, staging, and planning of treatment of disease and represent an important step toward personalized medicine applications. The combination of radioisotopes for nuclear imaging with fluorophores for fluorescence imaging provides the possibility to noninvasively assess disease burden in a patient using positron emission tomography/single-photon emission computed tomography, followed by fluorescence imaging-assisted surgical intervention in close succession. Probes enabling imaging with both modalities pose a design, synthesis, and pharmacokinetics challenge. In this study, the authors strive to summarize recent efforts toward optimized, discrete, bimodal probes as well as a perspective on future directions of this burgeoning subfield of targeted imaging probe development.
Collapse
Affiliation(s)
- Shin Hye Ahn
- Department of Chemistry, Stony Brook University , Stony Brook, New York
| | - Eszter Boros
- Department of Chemistry, Stony Brook University , Stony Brook, New York
| |
Collapse
|
15
|
Zhao J, Chen J, Ma S, Liu Q, Huang L, Chen X, Lou K, Wang W. Recent developments in multimodality fluorescence imaging probes. Acta Pharm Sin B 2018; 8:320-338. [PMID: 29881672 PMCID: PMC5989919 DOI: 10.1016/j.apsb.2018.03.010] [Citation(s) in RCA: 128] [Impact Index Per Article: 21.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2018] [Revised: 03/24/2018] [Accepted: 03/26/2018] [Indexed: 12/19/2022] Open
Abstract
Multimodality optical imaging probes have emerged as powerful tools that improve detection sensitivity and accuracy, important in disease diagnosis and treatment. In this review, we focus on recent developments of optical fluorescence imaging (OFI) probe integration with other imaging modalities such as X-ray computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), single-photon emission computed tomography (SPECT), and photoacoustic imaging (PAI). The imaging technologies are briefly described in order to introduce the strengths and limitations of each techniques and the need for further multimodality optical imaging probe development. The emphasis of this account is placed on how design strategies are currently implemented to afford physicochemically and biologically compatible multimodality optical fluorescence imaging probes. We also present studies that overcame intrinsic disadvantages of each imaging technique by multimodality approach with improved detection sensitivity and accuracy.
Collapse
Affiliation(s)
- Jianhong Zhao
- Shanghai Key Laboratory of Chemical Biology, School of Pharmacy, and State Key Laboratory of Bioengineering Reactor, East China University of Science and Technology, Shanghai 200237, China
| | - Junwei Chen
- Shanghai Key Laboratory of Chemical Biology, School of Pharmacy, and State Key Laboratory of Bioengineering Reactor, East China University of Science and Technology, Shanghai 200237, China
| | - Shengnan Ma
- Shanghai Key Laboratory of Chemical Biology, School of Pharmacy, and State Key Laboratory of Bioengineering Reactor, East China University of Science and Technology, Shanghai 200237, China
| | - Qianqian Liu
- Shanghai Key Laboratory of Chemical Biology, School of Pharmacy, and State Key Laboratory of Bioengineering Reactor, East China University of Science and Technology, Shanghai 200237, China
| | - Lixian Huang
- Shanghai Key Laboratory of Chemical Biology, School of Pharmacy, and State Key Laboratory of Bioengineering Reactor, East China University of Science and Technology, Shanghai 200237, China
| | - Xiani Chen
- Shanghai Key Laboratory of Chemical Biology, School of Pharmacy, and State Key Laboratory of Bioengineering Reactor, East China University of Science and Technology, Shanghai 200237, China
| | - Kaiyan Lou
- Shanghai Key Laboratory of Chemical Biology, School of Pharmacy, and State Key Laboratory of Bioengineering Reactor, East China University of Science and Technology, Shanghai 200237, China
| | - Wei Wang
- Shanghai Key Laboratory of Chemical Biology, School of Pharmacy, and State Key Laboratory of Bioengineering Reactor, East China University of Science and Technology, Shanghai 200237, China
- Department of Chemistry and Chemical Biology, University of New Mexico, Albuquerque, NM 87131-0001, USA
| |
Collapse
|
16
|
|
17
|
Cai Y, Lu D, Zou Y, Zhou C, Liu H, Tu C, Li F, Liu L, Zhang S. Curcumin Protects Against Intestinal Origin Endotoxemia in Rat Liver Cirrhosis by Targeting PCSK9. J Food Sci 2017; 82:772-780. [PMID: 28196290 DOI: 10.1111/1750-3841.13647] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2016] [Revised: 12/16/2016] [Accepted: 01/10/2017] [Indexed: 12/13/2022]
Abstract
Intestinal origin endotoxemia always occurs in severe liver injury. The aim of the current study was to test antiendotoxemia effect of curcumin on tetrachloride (CCl4 )-induced liver cirrhosis rats, and to elucidate the underlying molecular mechanism. Rat cirrhosis models were constructed with CCl4 subcutaneous injections with curcumin (200 mg/kg/d) administered via gavages for 12 wk until the rats were sacrificed. We found that the administration of curcumin improved the physiological condition pertaining to activity index and temperature, and ameliorated the liver injury in CCl4 -induced cirrhosis rats. Enzyme-linked immunosorbent assay (ELISA) and real-time quantitative polymerase chain reaction (qRT-PCR) showed that curcumin could reduce c-reaction protein levels and inflammatory cytokine (TNF-α, IL-1β, IL-6, and CINC-1/IL-8) concentrations in peripheral serum and liver tissue. Furthermore, curcumin treatment decreased lipopolysaccharide (LPS) levels in peripheral vein, but not in portal vein. As low-density lipoprotein receptor (LDLR) is the important receptor on the surface of hepatocyte during LPS detoxification process, we used qRT-PCR, western blot, and immunohistochemistry (IHC), finding that curcumin significantly increased LDLR protein levels, but not gene levels in the liver tissues. We also tested proprotein convertase subtilisin/kexin type 9 (PCSK9), one negative regulator of LDLR, by qRT-PCR, western blot, and IHC. The results showed that PCSK9 significantly decreased both gene and protein levels in the rat liver tissues of curcumin treatment. Thus, we concluded that curcumin could function to protect against intestinal origin endotoxemia by inhibiting PCSK9 to promote LDLR expression, thereby enhancing LPS detoxification as one pathogen lipid through LDLR in the liver.
Collapse
Affiliation(s)
- Yu Cai
- Dept. of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan Univ., 180 Fenglin Rd., Xuhui District, Shanghai, P.R. China
| | - Di Lu
- Dept. of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan Univ., 180 Fenglin Rd., Xuhui District, Shanghai, P.R. China
| | - Yanting Zou
- Dept. of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan Univ., 180 Fenglin Rd., Xuhui District, Shanghai, P.R. China
| | - Chaohui Zhou
- Dept. of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan Univ., 180 Fenglin Rd., Xuhui District, Shanghai, P.R. China
| | - Hongchun Liu
- Dept. of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan Univ., 180 Fenglin Rd., Xuhui District, Shanghai, P.R. China
| | - Chuantao Tu
- Dept. of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan Univ., 180 Fenglin Rd., Xuhui District, Shanghai, P.R. China
| | - Feng Li
- Dept. of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan Univ., 180 Fenglin Rd., Xuhui District, Shanghai, P.R. China
| | - Lili Liu
- Dept. of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan Univ., 180 Fenglin Rd., Xuhui District, Shanghai, P.R. China
| | - Shuncai Zhang
- Dept. of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan Univ., 180 Fenglin Rd., Xuhui District, Shanghai, P.R. China
| |
Collapse
|
18
|
Li L, Ding S, Yang Y, Zhu A, Fan X, Cui M, Chen C, Zhang G. Multicomponent Aqueous Synthesis of Iodo-1,2,3-triazoles: Single-Step Models for Dual Modification of Free Peptide and Radioactive Iodo Labeling. Chemistry 2016; 23:1166-1172. [DOI: 10.1002/chem.201605034] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2016] [Indexed: 12/19/2022]
Affiliation(s)
- Lingjun Li
- Collaborative Innovation Center of Henan Province for Green; Manufacturing of Fine Chemicals, Key Laboratory of Green Chemical; Media and Reactions, Ministry of Education; School of Chemistry and Chemical Engineering; Henan Normal University; Xinxiang Henan 453007 P.R. China
| | - Shengqiang Ding
- Collaborative Innovation Center of Henan Province for Green; Manufacturing of Fine Chemicals, Key Laboratory of Green Chemical; Media and Reactions, Ministry of Education; School of Chemistry and Chemical Engineering; Henan Normal University; Xinxiang Henan 453007 P.R. China
| | - Yanping Yang
- Key Laboratory of Radiopharmaceuticals, Ministry of Education; College of Chemistry; Beijing Normal University; Beijing 100875 P.R. China
| | - Anlian Zhu
- Collaborative Innovation Center of Henan Province for Green; Manufacturing of Fine Chemicals, Key Laboratory of Green Chemical; Media and Reactions, Ministry of Education; School of Chemistry and Chemical Engineering; Henan Normal University; Xinxiang Henan 453007 P.R. China
| | - Xincui Fan
- Collaborative Innovation Center of Henan Province for Green; Manufacturing of Fine Chemicals, Key Laboratory of Green Chemical; Media and Reactions, Ministry of Education; School of Chemistry and Chemical Engineering; Henan Normal University; Xinxiang Henan 453007 P.R. China
| | - Mengchao Cui
- Key Laboratory of Radiopharmaceuticals, Ministry of Education; College of Chemistry; Beijing Normal University; Beijing 100875 P.R. China
| | - Changpo Chen
- Collaborative Innovation Center of Henan Province for Green; Manufacturing of Fine Chemicals, Key Laboratory of Green Chemical; Media and Reactions, Ministry of Education; School of Chemistry and Chemical Engineering; Henan Normal University; Xinxiang Henan 453007 P.R. China
| | - Guisheng Zhang
- Collaborative Innovation Center of Henan Province for Green; Manufacturing of Fine Chemicals, Key Laboratory of Green Chemical; Media and Reactions, Ministry of Education; School of Chemistry and Chemical Engineering; Henan Normal University; Xinxiang Henan 453007 P.R. China
| |
Collapse
|
19
|
Maindron N, Ipuy M, Bernhard C, Lhenry D, Moreau M, Carme S, Oudot A, Collin B, Vrigneaud JM, Provent P, Brunotte F, Denat F, Goze C. Near-Infrared-Emitting BODIPY-trisDOTA(111) In as a Monomolecular Multifunctional Imaging Probe: From Synthesis to In Vivo Investigations. Chemistry 2016; 22:12670-4. [PMID: 27410465 DOI: 10.1002/chem.201602886] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2016] [Indexed: 01/01/2023]
Abstract
A new generation of monomolecular imaging probes (MOMIP) based on a distyryl-BODIPY (BODIPY=boron-dipyrromethene) coupled with three DOTA macrocycles has been prepared (DOTA=1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid). The MOMIP presents good fluorescence properties and is very stable in serum. The bimodal probe was conjugated to trastuzumab, and an optical in vivo study showed high accumulation of the imaging agent at the tumor site. (111) In radiometallation of the bioconjugate was performed in high radiochemical yield, highlighting the potential of this new BODIPY-chelators derivative as a bimodal imaging probe.
Collapse
Affiliation(s)
- Nicolas Maindron
- ICMUB UMR CNRS 6302, CNRS, Univ. Bourgogne Franche-Comté, 9, avenue Alain Savary, 21078, Dijon, France
| | - Martin Ipuy
- ICMUB UMR CNRS 6302, CNRS, Univ. Bourgogne Franche-Comté, 9, avenue Alain Savary, 21078, Dijon, France
| | - Claire Bernhard
- ICMUB UMR CNRS 6302, CNRS, Univ. Bourgogne Franche-Comté, 9, avenue Alain Savary, 21078, Dijon, France
| | - Damien Lhenry
- ICMUB UMR CNRS 6302, CNRS, Univ. Bourgogne Franche-Comté, 9, avenue Alain Savary, 21078, Dijon, France
| | - Mathieu Moreau
- ICMUB UMR CNRS 6302, CNRS, Univ. Bourgogne Franche-Comté, 9, avenue Alain Savary, 21078, Dijon, France
| | - Sabin Carme
- ICMUB UMR CNRS 6302, CNRS, Univ. Bourgogne Franche-Comté, 9, avenue Alain Savary, 21078, Dijon, France
| | - Alexandra Oudot
- Centre Georges François Leclerc, Service de médecine nucléaire, 1 rue Professeur Marion, BP77980, 21079, Dijon Cedex, France
| | - Bertrand Collin
- ICMUB UMR CNRS 6302, CNRS, Univ. Bourgogne Franche-Comté, 9, avenue Alain Savary, 21078, Dijon, France.,Centre Georges François Leclerc, Service de médecine nucléaire, 1 rue Professeur Marion, BP77980, 21079, Dijon Cedex, France
| | - Jean-Marc Vrigneaud
- Centre Georges François Leclerc, Service de médecine nucléaire, 1 rue Professeur Marion, BP77980, 21079, Dijon Cedex, France
| | - Peggy Provent
- Oncodesign, 20 rue Jean Mazen, BP27627, 21076, Dijon CEDEX, France
| | - François Brunotte
- Centre Georges François Leclerc, Service de médecine nucléaire, 1 rue Professeur Marion, BP77980, 21079, Dijon Cedex, France
| | - Franck Denat
- ICMUB UMR CNRS 6302, CNRS, Univ. Bourgogne Franche-Comté, 9, avenue Alain Savary, 21078, Dijon, France.
| | - Christine Goze
- ICMUB UMR CNRS 6302, CNRS, Univ. Bourgogne Franche-Comté, 9, avenue Alain Savary, 21078, Dijon, France.
| |
Collapse
|
20
|
Bodio E, Le Gendre P, Denat F, Goze C. Development of Trackable Anticancer Agents Based on Metal Complexes. ADVANCES IN INORGANIC CHEMISTRY 2016. [DOI: 10.1016/bs.adioch.2015.09.004] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
|
21
|
Gadolinium(III)-DOTA Complex Functionalized with BODIPY as a Potential Bimodal Contrast Agent for MRI and Optical Imaging. INORGANICS 2015. [DOI: 10.3390/inorganics3040516] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023] Open
|
22
|
Lhenry D, Larrouy M, Bernhard C, Goncalves V, Raguin O, Provent P, Moreau M, Collin B, Oudot A, Vrigneaud JM, Brunotte F, Goze C, Denat F. BODIPY: A Highly Versatile Platform for the Design of Bimodal Imaging Probes. Chemistry 2015. [DOI: 10.1002/chem.201501676] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
|
23
|
Pais de Barros JP, Gautier T, Sali W, Adrie C, Choubley H, Charron E, Lalande C, Le Guern N, Deckert V, Monchi M, Quenot JP, Lagrost L. Quantitative lipopolysaccharide analysis using HPLC/MS/MS and its combination with the limulus amebocyte lysate assay. J Lipid Res 2015; 56:1363-9. [PMID: 26023073 DOI: 10.1194/jlr.d059725] [Citation(s) in RCA: 85] [Impact Index Per Article: 9.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2015] [Indexed: 01/22/2023] Open
Abstract
Quantitation of plasma lipopolysaccharides (LPSs) might be used to document Gram-negative bacterial infection. In the present work, LPS-derived 3-hydroxymyristate was extracted from plasma samples with an organic solvent, separated by reversed phase HPLC, and quantitated by MS/MS. This mass assay was combined with the limulus amebocyte lysate (LAL) bioassay to monitor neutralization of LPS activity in biological samples. The described HPLC/MS/MS method is a reliable, practical, accurate, and sensitive tool to quantitate LPS. The combination of the LAL and HPLC/MS/MS analyses provided new evidence for the intrinsic capacity of plasma lipoproteins and phospholipid transfer protein to neutralize the activity of LPS. In a subset of patients with systemic inflammatory response syndrome, with documented infection but with a negative plasma LAL test, significant amounts of LPS were measured by the HPLC/MS/MS method. Patients with the highest plasma LPS concentration were more severely ill. HPLC/MS/MS is a relevant method to quantitate endotoxin in a sample, to assess the efficacy of LPS neutralization, and to evaluate the proinflammatory potential of LPS in vivo.
Collapse
Affiliation(s)
- Jean-Paul Pais de Barros
- INSERM, LNC UMR866, F-21000 Dijon, France LNC UMR866, University Bourgogne Franche-Comté, F-21000 Dijon, France LipSTIC LabEx, Fondation de Coopération Scientifique Bourgogne-Franche Comté, F-21000 Dijon, France
| | - Thomas Gautier
- INSERM, LNC UMR866, F-21000 Dijon, France LNC UMR866, University Bourgogne Franche-Comté, F-21000 Dijon, France LipSTIC LabEx, Fondation de Coopération Scientifique Bourgogne-Franche Comté, F-21000 Dijon, France
| | - Wahib Sali
- INSERM, LNC UMR866, F-21000 Dijon, France LNC UMR866, University Bourgogne Franche-Comté, F-21000 Dijon, France LipSTIC LabEx, Fondation de Coopération Scientifique Bourgogne-Franche Comté, F-21000 Dijon, France
| | - Christophe Adrie
- Physiology Department, Cochin Hospital, Paris University, Paris, France
| | - Hélène Choubley
- LipSTIC LabEx, Fondation de Coopération Scientifique Bourgogne-Franche Comté, F-21000 Dijon, France
| | - Emilie Charron
- LipSTIC LabEx, Fondation de Coopération Scientifique Bourgogne-Franche Comté, F-21000 Dijon, France
| | - Caroline Lalande
- LipSTIC LabEx, Fondation de Coopération Scientifique Bourgogne-Franche Comté, F-21000 Dijon, France
| | - Naig Le Guern
- INSERM, LNC UMR866, F-21000 Dijon, France LNC UMR866, University Bourgogne Franche-Comté, F-21000 Dijon, France LipSTIC LabEx, Fondation de Coopération Scientifique Bourgogne-Franche Comté, F-21000 Dijon, France
| | - Valérie Deckert
- INSERM, LNC UMR866, F-21000 Dijon, France LNC UMR866, University Bourgogne Franche-Comté, F-21000 Dijon, France LipSTIC LabEx, Fondation de Coopération Scientifique Bourgogne-Franche Comté, F-21000 Dijon, France
| | - Mehran Monchi
- Intensive Care Unit, Melun General Hospital, Melun, France
| | - Jean-Pierre Quenot
- INSERM, LNC UMR866, F-21000 Dijon, France LNC UMR866, University Bourgogne Franche-Comté, F-21000 Dijon, France LipSTIC LabEx, Fondation de Coopération Scientifique Bourgogne-Franche Comté, F-21000 Dijon, France Intensive Care Unit University Hospital of Dijon, F-21000 Dijon, France
| | - Laurent Lagrost
- INSERM, LNC UMR866, F-21000 Dijon, France LNC UMR866, University Bourgogne Franche-Comté, F-21000 Dijon, France LipSTIC LabEx, Fondation de Coopération Scientifique Bourgogne-Franche Comté, F-21000 Dijon, France Clinical Research Department, University Hospital of Dijon, F-21000 Dijon, France
| |
Collapse
|
24
|
Yazdani A, Janzen N, Banevicius L, Czorny S, Valliant JF. Imidazole-Based [2 + 1] Re(I)/99mTc(I) Complexes as Isostructural Nuclear and Optical Probes. Inorg Chem 2015; 54:1728-36. [PMID: 25634699 DOI: 10.1021/ic502663p] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Affiliation(s)
- Abdolreza Yazdani
- Department of Chemistry
and Chemical Biology, McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4M1, Canada
| | - Nancy Janzen
- Centre for Probe Development and Commercialization, 1280 Main Street West, Hamilton, Ontario L8S 4M1, Canada
| | - Laura Banevicius
- Centre for Probe Development and Commercialization, 1280 Main Street West, Hamilton, Ontario L8S 4M1, Canada
| | - Shannon Czorny
- Centre for Probe Development and Commercialization, 1280 Main Street West, Hamilton, Ontario L8S 4M1, Canada
| | - John F. Valliant
- Department of Chemistry
and Chemical Biology, McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4M1, Canada
- Centre for Probe Development and Commercialization, 1280 Main Street West, Hamilton, Ontario L8S 4M1, Canada
| |
Collapse
|
25
|
Doulain PE, Decréau R, Racoeur C, Goncalves V, Dubrez L, Bettaieb A, Le Gendre P, Denat F, Paul C, Goze C, Bodio E. Towards the elaboration of new gold-based optical theranostics. Dalton Trans 2015; 44:4874-83. [DOI: 10.1039/c4dt02977a] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
Four new red BODIPY–gold(i) theranostic compounds were synthesized.
Collapse
|
26
|
Brasse D, Nonat A. Radiometals: towards a new success story in nuclear imaging? Dalton Trans 2015; 44:4845-58. [DOI: 10.1039/c4dt02911a] [Citation(s) in RCA: 42] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
The use of radiometal isotopes in positron emission tomography: a new success story in nuclear imaging?
Collapse
Affiliation(s)
- David Brasse
- Université de Strasbourg
- 67037 Strasbourg
- France
- CNRS
- UMR7178
| | - Aline Nonat
- Université de Strasbourg
- 67087 Strasbourg
- France
- CNRS
- UMR7178
| |
Collapse
|
27
|
Chevalier A, Renault K, Boschetti F, Renard PY, Romieu A. Rapid Synthesis of Unsymmetrical Sulforhodamines Through Nucleophilic Amination of a Monobrominated Sulfoxanthene Dye. European J Org Chem 2014. [DOI: 10.1002/ejoc.201403165] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
|
28
|
Brizet B, Goncalves V, Bernhard C, Harvey PD, Denat F, Goze C. DMAP-BODIPY Alkynes: A Convenient Tool for Labeling Biomolecules for Bimodal PET-Optical Imaging. Chemistry 2014; 20:12933-44. [DOI: 10.1002/chem.201402379] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2014] [Indexed: 11/11/2022]
|